CTLA-4 |
cytotoxic T-lymphocyte-associated protein 4 |
C4 |
Complement component 4 |
EBV |
Epstein-Barr virus |
GM |
gut microbiota |
GPR41-GPR43 |
G protein-coupled receptors |
HCT |
hematopoietic cell transplantation |
HCV |
hepatitis C virus |
HHV-8 |
human herpesvirus 8 |
HIV |
human immunodeficiency virus |
HMP |
Human Microbiome Project |
IL10 |
Interleukin 10 |
IFN |
Interferon |
irAEs |
immune related adverse events |
LBP |
LPS binding protein |
LPS |
lipopolysaccharide |
MALT |
mucosal-associated lymphoid tissue |
MD |
Microbial translocation |
MS |
multiple sclerosis |
NF-kB |
nuclear factor kappa-light-chain-enhancer of activated B cells |
NGS |
next generation sequencing |
NOD-1 |
Nucleotide-binding oligomerization domain-containing protein 1 |
NSCLC |
non–small cell lung cancer |
PAMPs |
pathogen associated molecular patterns |
PD-1 |
programmed cell death protein 1 |
PD-L1 |
programmed cell death protein 1 ligand |
PTLD |
post-transplantation lymphoproliferative disorder |
ROS |
reactive oxygen species |
sCD14 |
soluble CD14 |
SCFAs |
short-chain fatty acids |
SPF |
specific pathogen-free |
TLRs |
Toll-like receptors |
Th1-Th17 |
T helper cells |
Treg |
regulatory T cell |
VLP |
virus-like particles |